SmartMoneyDB

IKTINHIBIKASE THERAPEUTICS INC

COM NEW · CUSIP 45719W205

IKT (INHIBIKASE THERAPEUTICS INC) Institutional Ownership Summary

Based on the latest SEC 13F filings, 2 institutional investors hold IKT (INHIBIKASE THERAPEUTICS INC) with a combined value of $9.33M across 4,549,204 shares. The largest holder is BlackRock, Inc. with a position worth $6.78M (0.00% of their portfolio). 2 funds increased their holdings.

Total Institutional Value

$9.33M

Total Shares Held

4,549,204

Institutional Holders

2

13F Institutional Holders

#FundValuePortfolio %Change
1BlackRock, Inc.$6.78M0.00%+7.5%
2CITADEL ADVISORS LLC$2.55M0.00%+1635.2%